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ABSTRACT 
 
Neurotensin (NTS) is a tridecapeptide which is widely distributed in the central 
nervous system and digestive tract. It is highly expressed in neurons of the 
hypothalamus, a region of the brain known to control feeding behavior. Several studies 
have shown that intracerebroventricular injection of NTS decreased food intake in rats. 
NTS was therefore characterized and analyzed for associations with growth and carcass 
traits in beef cattle. 
 NTS mRNA was successfully isolated from brain, spinal cord, abomasum, 
rumen wall, small intestine and skin samples. The complete bovine mRNA sequence 
was obtained from skin, along with partial genomic sequence. Three single nucleotide 
polymorphisms (SNPs) in the 3’ untranslated region (3’UTR) and six intronic SNPs 
were identified. The three SNPs in the 3’UTR were not in linkage disequilibrium. Of 
the three SNPs in the 3’UTR, two had minor allele frequencies of 2% and therefore 
were not analyzed further. The minor allele frequencies for the third SNP (*419G>A) 
ranged between 0% and 23% for four major beef breeds. The *419G>A SNP was also 
used to map NTS to bovine chromosome five between markers BM6026 (13 cM, 
LOD=4.03) and RM103 (4 cM, LOD=3.63). 
 No significant associations between the *419G>A SNP and growth traits were 
identified. Statistical analysis revealed significant genotype associations for rib eye area 
(REA), grade fat and moisture in the Canadian Beef Reference Herd (CBRH). These 
associations were not verified in a second group of purebred yearling bulls. However, 
significant associations with end of trial fat, %fat and fat deviation were associations for 
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marbling and quality grade. In all cases the AA genotype was associated with increased 
fat. 
 Although significant associations between carcass measurements and genotype 
at the *491G>A SNP were present in some populations, none of these associations were 
found in more than one population. It was therefore concluded that the *419G>A SNP 
on the bovine NTS gene does not prove to have an economic advantage to the beef cattle 
industry.  
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1.0 GENERAL INTRODUCTION 
 
Neurotensin (NTS) is a 13 amino acid (aa) peptide (Gln-Leu-Tyr-Glu-Asn-Lys-
Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH) which was first isolated from bovine hypothalamus 
by Carraway and Leeman in 1973. In rats, the injection of NTS has been shown to 
decrease food intake and body weight (Luttinger et al. 1982, Levine et al. 1983, Stanley 
et al. 1985, Sahu 1998, Beck et al. 1998). The injection of NTS has also been shown to 
influence gastrointestinal function (Evers 2002).  
Several polymorphisms have been identified in the neurotensin gene in humans 
and analyzed for associations with neuropsychiatric disorders, alcohol dependence and 
restless leg syndrome, however, no studies have focused on polymorphisms within the 
cattle NTS gene. NTS was therefore studied as a candidate gene in this study for 
optimizing growth traits in beef cattle based on the evidence that NTS decreases food 
intake and body weight in rodent species. In turn, potential NTS genotype associations 
with growth traits may prove to be an economic benefit to the beef cattle industry. 
Therefore, this thesis focuses on the characterization of NTS in cattle and its potential 
associations with growth traits.  
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2.0 LITERATURE REVIEW 
2.1 NTS Gene Structure 
 
 Cloning and sequence analysis of cDNA for canine NTS revealed the primary 
structure of the 170 aa precursor protein (Figure 2.1) that encodes both NTS and 
neuromedin N (NN) (Dobner et al. 1987). The NN/NTS coding domains are tandemly 
positioned on exon 4 with NN proceeding NTS in the precursor sequence (Dobner et al. 
1987). The NTS and NN sequences are both flanked and separated by three Lys-Arg 
sequences (Figure 2.1; Dobner et al. 1987).  
Neuromedins are a novel family of peptides isolated from porcine spinal cord in 
the 1980’s based on their ability to contract smooth muscle (Brighton et al. 2004). This 
family of peptides includes the neuromedins B and C (bombesin-like), K (neurokinin B) 
and L (neurokinin A, substance K, or neurokinin ∝), N (neurotensin-like), and U 
(Brighton et al. 2004). Neuromedins are found in many tissues including the central 
nervous system and have been shown to influence a wide variety of physiological 
functions (Brighton et al. 2004). Only neuromedin N is encoded by the gene studied 
here. 
NN is a 6 aa peptide (Lys-Ile-Pro-Tyr-Ile-Leu-OH) that shares strong homology 
with the C-terminal of NTS with the four carboxyl-terminal aa’s of NTS being identical 
(Minamino et al. 1984). Neuromedin N produces a contractile activity on 
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     Met Met Ala Gly Met 
TTTATGGACTTGGCTTGCTAGAAGGCTCAAGGAG ATG ATG GCA GGA ATG   49 
 
Lys Ile Gln Leu Val Cys Met Ile Leu Leu Ala Phe Ser Ser 
AAA ATC CAG CTG GTG TGC ATG ATA CTT CTG GCT TTC ACG TCC  91 
 
Trp Ser Leu Cys Ser Asp Ser Glu Glu Glu Met Lys Ala Leu 
TGG AGT CTG TGC TCA GAT TCA GAA GAG GAA ATG AAA GCA TTA 133 
 
Glu Ala Asp Leu Leu Thr Asn Met His Thr Ser Lys Ile Ser 
GAA GCA GAT TTA TTG ACC AAT ATG CAT ACA TCA AAG ATC AGT 175 
 
Lys Ala Ser Val Ser Ser Trp Lys Met Thr Leu Leu Asn Val 
AAA GCA AGT GTT TCT TCT TGG AAA ATG ACC CTG CTA AAT GTT 217 
 
Cys Ser Phe Val Asn Asn Leu Asn Ser Gln Ala Glu Glu Thr 
TGC AGT TTT GCT AAT AAC CTG AAC AGC CAA GCC GAG GAA ACA 259 
 
Gly Glu Phe Arg Glu Glu Glu Leu Ile Thr Arg Arg Lys Phe 
GGA GAG TTT CAT GAA GAG GAG CTT ATT ACA AGA AGG AAA TTT 301 
 
Pro Thr Ala Leu Asp Gly Phe Ser Leu Glu Ala Met Leu Thr 
CCC ACT GCC TTG GAT GGC TTT AGC TTG GAA GCA ATG TTG ACA 343 
 
Ile Try Gln Leu Gln Lys Ile Cys His Ser Arg Ala Phe Gln 
ATA TAC CAG CTC CAA AAA ATC TGT CAC AGC AGG GCC TTT CAA 385 
 
Gln Trp Glu Leu Ile Gln Glu Asp Val Leu Asp Ala Gly Asn 
CAA TGG GAG TTA ATC CAG GAA GAT GTT CTT GAT GAT GGA AAT 427 
 
Asp Lys Asn Glu Lys Glu Glu Val Ile Lys Arg Lys Ile Pro 
GAC AAA AAT GAA AAG GAA GAG GTT ATA AAG AGA AAA ATC CCT 469 
 
Tyr Ile Leu Lys Arg Gln Leu Tyr Glu Ans Lys Pro Arg Arg 
TAT ATT CTG AAA CGG CAG CTA TAT GAG AAT AAA CCC AGA AGA 511 
 
Pro Tyr Ile Leu Lys Arg Gly Ser Tyr Tyr Tyr ---         547 
CCC TCA ATA CTC AAG AGA GGT TCT TAC TAC TAC TGA 
 
  
 
 
Figure 2.1: Predicted amino acid sequence from DNA sequence of canine 
preproneurotensin/neuromedin N. The NN and NTS coding regions are boxed by solid 
lines and a region similar to NN is underlined (adapted from Dobner et al. 1987). 
Numbers to the right indicate the final nucleotide position in each row. Arrows indicate 
exon boundaries.
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the ileum in guinea pigs and induces a hypotensive response that is similar to 
neurotensin. 
A study by Kislauskis et al. (1988) identified that the rat NTS gene spans 
approximately 10.2 kilo bases (kb) and is divided into four exons as revealed by 
comparison with two heterologous cDNA sequences from the dog and cow. The cattle 
cDNA sequence for NTS was found to span 1166 bps, which contained the four exons 
as well as the 5’ and 3’ untranslated regions (UTRs) (Figure 2.2). The cattle cDNA 
sequence was significantly longer than the dog sequence which consisted of 759 bp. 
This was due to the shortened 3’ UTR of the dog cDNA (Kislauskis et al. 1988).  
Full-length human NN/NTS cDNA was first cloned by Dong et al. (1998). The 
NTS cDNA in the human consists of 1241bp (GenBank NM 006183). This difference in 
nucleotide length compared to cattle also occurs in the 3’ and 5’ untranslated regions. 
 
2.2  Expression 
 
Like many polypeptide hormones or neuropeptide precursors, NN/NTS precursor 
undergoes differential processing in tissues, which gives rise to different combinations 
of peptides (Friry et al. 2002). A study by Kislauskis et al. (1988) stated that RNA blot 
analysis revealed that the rat NN/NTS gene is transcribed to yield two distinct mRNAs, 
1.0 kb and 1.5 kb in size. These two mRNAs result from the differential utilization of 
two consensus poly (A) addition signals and differ in the length of their 3’ untranslated 
region (Kislauskis et al. 1988). They also identified that there was a striking variation in 
the relevant levels of these two mRNAs between the brain and intestine. They 
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Figure 2.2: A schematic diagram of the exon sizes in the cattle NTS gene.
Exon 1 
61 bp     73 bp 
Exon 2 
62 bp 
Exon 3 
225 bp 
Exon 4 
150 bp          595bp 
    Start       NN NTS Stop 
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concluded that the smaller (1.0 kb) mRNA greatly predominates in the intestine while 
both mRNA species are almost equally abundant in the hypothalamus. 
These results were supported by Rostene and Alexander (1997), who indicated 
that the NN/NTS precursor protein contained four potential sites of proteolytic cleavage 
by which NTS, NN and extended forms of each could be generated. De Nadia et al. 
(1994) identified that the posttranslational processing of the NN/NTS precursor yields 
NTS. This basic pattern of NN/NTS processing appears to be similar throughout the 
brain (De Nadia et al. 1994). However, the predominant molecular form of NN in the 
gastrointestinal tract differs from that in the brain, with mammalian intestine containing 
predominantly extended forms of NN (Carraway and Mitra 1990).  
A more recent study by Friry et al. (2002) also supported these findings and 
stated that in the brain, NN/NTS processing gives rise to NTS and NN whereas in the gut, 
processing leads mainly to the formation of NTS and a large peptide ending with the NN 
sequence at its C-terminus.  
In the rat hypothalamus, neurosecretory cells capable of NTS synthesis are 
located in specialized groups of nerve cells in the brain (arcuate nucleus) and the 
paraventricular nucleus (PVN) (large neurons of the front half of the hypothalamus) 
(Rostene and Alexander 1997). In some of these cells, NTS coexists with other 
neurohormones or transmitter-synthesizing enzymes (Rostene and Alexander 1997). 
A study by Evers et al. (1991) found that NTS was expressed throughout the 
small intestine of the adult rat, with the greatest abundance in the mid and distal 
intestine. In contrast, NTS was not expressed in the adult pancreas, stomach or colon.  
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NTS is localized in the brain and specialized endocrine cells (N-cells) dispersed 
throughout the mucosa of the small intestine (Reinecke 1985). In most brain regions, 
including the hypothalamus, NTS mRNA is first detected in the perinatal period and 
levels gradually increase to reach a plateau by adulthood (Rostene and Alexander 1997) 
(Figure 2.3). 
The study by Evers et al. (1993) characterized the development pattern of 
NN/NTS expression in the gut of both humans and rats. They found that NTS expression 
in the small intestine is initially low in the fetal rat, however, the expression is 
dramatically increased three days postnatal. After postnatal day 28, NTS mRNA levels 
remained relatively constant in the ileum but were decreased in the jejunum. 
Furthermore, similar to the rat, NTS expression was low in the human fetal ileum but 
was dramatically increased in the adult. The jejunum and ileum show a similar pattern 
of expression until the end of the fourth postnatal week. NN/NTS is transiently 
expressed in the colon of rats and humans during a development stage similar to the 
small intestine. 
 
2.3 Receptors 
 
 NTS mediates its effects through cell surface receptors, which are distributed 
heterogeneously in the CNS with both high and low affinity sites (Goedert et al. 1984). 
In the rat brain, Goedert et al. (1984) found that the highest density of binding sites 
were located in the hypothalamus and the frontal cortex, with intermediate sites in the 
striatum, thalamus and midbrain and low levels in the cerebellum. The review by  
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Figure 2.3: NTS expression in the small intestine. 
 
 
 
 
 
Figure 2.4: NTS expression in the stomach. 
Fetal Postnatal Puberty 
Small Intestine 
Fetal Postnatal Puberty 
Stomach 
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Figure 2.5: NTS expression in the hypothalamus. 
Fetal Postnatal Puberty 
Hypothalamus 
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Dobner (2005) states that NTS and NN appear to have largely overlapping functions and 
bind to a common group of receptors that include two G protein-coupled receptors 
(NTR1 and NTR2) and two predominately intracellular receptors (NTR3/sortilin and 
NTR4/SorLA). 
NTR1 was the first NTS receptor to be cloned (Tanaka et al. 1990). It was 
identified as a G protein-coupled protein which showed a selective and high affinity 
binding to NTS peptides. This receptor appears to mediate most of the pharmacological 
and physiological effects of NTS (Dobner 2005).  
The second NTS receptor (NTR2), cloned by Mazella et al. in 1996, was shown 
to share substantial sequence identity with NTR1, but was pharmacologically distinct. 
The pharmacological properties of NTR2 correspond to those of a low-affinity, 
levocabastine-sensitive NTS binding site, which is highly expressed in the cerebellum 
and hippocampus of the adult mouse brain. Levocabastine is a selective second-
generation H1 receptor antagonist which is more selective for peripheral H1 receptors. 
The physiological functions of NTR2 however, remain uncertain. However, there is 
increasing evidence that NTR2 may mediate certain analgesic effects of NTS (Dobner 
2005).  
Mazella et al. (1998) cloned NTR3 which corresponds to the protein designated 
gp95/sortilin previously purified and cloned. This receptor was then designated as the 
NTR3/sortilin receptor and was described as the first neuropeptide receptor that did not 
belong to the family of G-protein-coupled receptors. 
 Jacobsen et al. (2001) isolated and sequenced NTR4 also known as 
SorLA/LR11, a mosaic protein. SorLA was shown to have similarities with 
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NTR3/sortilin. Both are synthesized as a proreceptor that is later cleaved. NTR3 and 
NTR4 receptors appear to function primarily in receptor internalization and ligand 
degradation (Dobner 2005). Although these two receptors may mediate some functions 
of NTS, the available evidence suggests that most of the physiological functions and 
pharmacological effects of NTS are mediated by NTR1 (Dobner 2005). 
 
2.4 Functional Aspects of NTS 
2.4.1 Central Nervous System 
 
Different functions of NTS have been studied in a vast number of systems within 
varying organisms. One of the first reported effects of NTS was observed after direct 
injection into the brain, where it induced hypothermia (Bissette et al. 1976). The study 
by Bissette et al. (1976) looked at hypothermia and intolerance to cold induced by 
intracisternal (IC) and intravenous (IV) administration of NTS in mice. The IC 
administration of NTS decreased the core temperature in a dose related manner. In 
contrast, there were no significant effects on cold tolerance after IV administration. 
Therefore, Bissette et al. (1974) concluded that NTS can be included in the list of 
peptides which seem to directly influence the CNS.  
A study by Nemeroff et al. (1977) also identified that centrally administered 
NTS lowers body temperature in rats and mice, in a dose-related fashion. They also 
showed a reduction in locomotor activity after NTS administration. The hypothermic 
effects of NTS were not present after peripheral administration, suggesting that the 
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peptide is not able to cross the blood-brain barrier in sufficient quantities to exert direct 
brain effects. 
The next major CNS effect of centrally administered NTS described was its pain 
reducing effects (Clineschmidt et al. 1979). This study identified that NTS administered 
IC in mice increased the reaction time in a hot plate test and decreased writhing induced 
by acetic acid. The antinociception (increased tolerance to pain) effect of NTS lasted 
about an hour. The mice were also identified to be hypothermic and have reduced 
locomotor activity. These effects were not identified after the IV administration of NTS. 
This reduction in sensitivity is normally produced when an opium containing substance 
(opioid) combines with a receptor. Importantly, NTS-induced antinociception is not 
mediated through the opioid system, because NTS was not antagonized by naloxone (a 
narcotic analgesic antagonist used in the reversal of acute narcotic analgesic respiratory 
depression) (Clineschmidt et al. 1979). Therefore, it was suggested that the NTS effects 
result from an interaction of the peptide with NTS-specific receptor sites in the CNS.  
 
2.4.1.1 Antipsychotic Drug  
 
NTS was formally proposed to be a possible endogenous neuroleptic (a 
tranquilizing drug used to treat mental disorders) 27 years ago based on the fact that 
central NTS administration produced a spectrum of effects that were similar to those of 
antipsychotic drugs (APD) (Nemeroff 1980). Nemeroff (1980) identified that IC or 
intracerebroventricular (ICV) injected NTS produced: potentiation of barbiturate 
sedation, hypothermia, diminished locomotor activity and muscle relaxation in rats, all 
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of which are also caused by neuroleptics. In addition, bilateral nucleus accumbens 
injections of NTS, like haloperidol (a major antipsychotic agent), antagonized increased 
locomotor activity and rearing induced by d-amphetamine. Hypothermia and muscle 
relaxation which is induced by either NTS or neuroleptics is antagonized by IC injection 
of thyroid-releasing hormone. These findings, therefore, support the hypothesis that 
NTS is a neuromodulator as shown by its similarity to neuroleptics.  
Decreased NTS signaling has been shown to contribute to defects in 
sensorimotor gating in animal models of schizophrenia in a study by Binder et al. 
(2001b). Sensorimotor gating was assessed in rats by measuring the acquisition of latent 
inhibition and the prepulse inhibition of the acoustic startle reflex. APD-induced 
enhancement of latent inhibition and disrupted prepulse inhibition has been shown to 
have predictive validity for APD activity. The disruption of NTS neurotransmission, 
using a NTS receptor antagonist, blocked the behavioral effects of APD in these two 
distinct tests for sensorimotor gating. These results suggest that the development of 
direct NTS agonists may provide novel therapeutic approaches toward the treatment of 
schizophrenia in humans (Binder et al. 2001b). 
The review by Binder et al. (2001a) identified that both typical and atypical 
APD increase NTS mRNA expression, NTS peptide concentrations and cause NTS 
release into the nucleus accumbens. Typical APD are those which are effective in 
reducing the positive symptoms of schizophrenia (e.g. delusions and hallucinations) 
whereas atypical APD improve both positive and negative symptoms (e.g. social 
withdrawl and amotivation) (Kinkead et al. 1999). This suggests that the mechanisms 
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underlying both the therapeutic and side effects of APD treatment might involve 
increased NTS signaling in the nucleus accumbens (Binder et al. 2001a).  
 
2.4.1.2 Appetite Control 
 
Several peptides have been found to be present in both the gut and brain. 
Suggestions indicate that within the CNS, these peptides may be involved in digestive 
functions that are complementary to their function in the periphery. Bombesin is one 
example of a peptide which is located in the gut and the brain and has been shown to 
cause a reduction in food intake after both peripheral and central administration in rats. 
Because NTS is also found in both the brain and gut, Luttinger et al. (1982) decided to 
study the effects on NTS on food consumption.  
 Luttinger et al. (1982) looked at the effect of NTS on food consumption through 
the use of Sprague-Dawley albino rats which were deprived of food for 24 hours. The 
experimental group was administered 10 µl of a 0.9% saline solution containing 30 µg 
of NTS through ICV injections. Intracerebroventricular injection of NTS produced a 
dose-related decrease in food intake. This decrease was augmented at one hour post 
administrations, with recovery of intake occurring around three hours. ICV injection of 
NTS after the ingestion of a novel flavor did not produce a flavor aversion. 
 A similar study by Levine et al. (1983) also looked at the effect on NTS on feed 
intake, but did so through the examination of NTS on multiple feeding paradigms in 
rats.  ICV injection of NTS was once again shown to decrease food intake after 30 hrs of 
starvation compared to the controls. Norepinephrine and insulin induced feeding was 
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also decreased after NTS injection, however, muscimol (chemical substance which acts 
on the CNS to alter behavior) induced feeding was not. The study also showed that an 
intact vagus nerve is not necessary for NTS effects, for NTS decreased food intake in 
vagomatized rats (Levine et al. 1983). 
 NTS extended the suppression of feeding elicited by norepinephrine when 
injected into the PVN of rats (Stanley et al. 1985). NTS injected into the PVN ipsilateral 
to norepinephrine was more effective than contralateral, suggesting that NTS and 
norepinephrine interact in an anatomically site-specific manner (Stanley et al. 1985). 
These authors suggested that the reduction in feed intake may be partially behavior 
specific.  
 Hawkins (1986) examined the injections of NTS into the nucleus accumbens, 
ventromedial hypothalamus and cerebroventriculum of rats. Although no effect was 
seen in the nucleus accumbens, a reduction in feed intake was observed from injections 
into two other brain areas; with a maximum response occurring at approximately 90 
min after the highest dose of NTS was administered. This time may reflect the ability of 
NTS to be degraded by peptidases in the CNS, which supports the contention that 
endogenous NTS may act as a satiety factor via its effects on the CNS. 
In humans, meal stimulation caused NTS concentrations in the blood to increase 
100-300% within 30 min following the meal (Melchior et al. 1994). They looked at 
three experimental sessions to determine their influence on NTS concentrations. In the 
first session, subjects were fasted after their usual breakfast; in the second session 
subjects received a warm palatable meal following breakfast and in the third session 
participants received a cold, poorly acceptable meal following breakfast. NTS 
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concentrations were significantly higher after both meals than during the fasting 
session. The NTS increase was significantly higher following the palatable meal, than 
during the fasting session or the cold meal session, when measured thirty minutes after 
consumption.  
Leptin is one of the major peripheral signals that controls food intake and body 
weight (Sahu 1998). It is defined as a blood borne factor that is generated from the 
Obese gene which has been shown to decrease food intake and body weight in 
association with an increase in NTS (Sahu 1998). Sahu (1998) also identified that leptin 
inhibits the gene expression of neurons which are excitatory (e.g. neuropeptide Y) and 
stimulates expression of those which are inhibitory (e.g. NTS).  
The interaction between leptin and NTS was studied by Beck et al. (1998). They 
focused on NTS for several reasons. First, it is present in brain areas such as the PVN 
where the existence of leptin receptors have been detected. Second, it inhibits food 
intake when it is injected in these areas of the brain or in the brain ventricles. Finally, its 
secretion is triggered by fat digestion and hypothalamic contents are sensitive to diet 
composition.  ICV injection of NTS in rats caused a short lasting (30 min) inhibitory 
effect of NTS on food intake (Beck et al. 1998). The effect of ICV injection of leptin 
was observed after 24 hours. Co-injection with leptin, increased NTS effects at 30 
minutes and prolonged it for an additional 30 minutes, while NTS increased the effect of 
leptin at 30 and 60 minutes, but not at 24 hours.  
Beck et al. (1998) also identified that NTS concentrations were augmented in 
selective brain areas in fat-preferring rats. This increase was observed in the 
parvocellular part of the PVN and was associated with an increase in circulating leptin 
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levels. These results suggest that the short-term anorexigenic effects of leptin in normal 
rats are partly mediated by changes in NTS processing or release. Therefore, the NTS 
increase observed in fat-preferring rats would limit the over consumption of energy, a 
physiological mechanism translated by leptin.  
Another study by Sahu et al. (2001) looked at the relative role of NTS in 
mediating leptin’s action by examining the effects of NTS antiserum and NTS receptor 
antagonist on the satiety action of leptin in the rat. Administration of 4 µg of leptin 
decreased relative food intake, while prior administration of NTS antiserum (5 µl) 
completely blocked the effects of leptin on food intake. The effect of leptin on food 
intake was also completely abolished by prior intraperitoneal (IP) administration of NTS 
receptor antagonist at 2, 4 and 6 hr periods. They conclude that this neuropeptide is a 
quantitatively important component of the leptin sensitive neural circuity.  
The potential involvement of NTS in food intake and body weight regulation is 
evident from the findings that the central administration of NTS inhibits food intake in 
the rat (Beck et al. 1998, Levine et al. 1983, Luttinger et al. 1982, Sahu 1998, 
Stanley et al. 1985). The NTS gene expression and peptide levels are decreased in obese 
rats and the NTS expression has also been shown to increase in response to leptin (Sahu 
1998).  
Tritos et al. (1998) suggest that a number of peptides expressed in the 
mammalian hypothalamus are involved in the regulation of food intake and energy 
balance. These authors suggested that melanin-concentrating hormone and neuropeptide 
Y are appetite stimulants, whereas melanocyte-stimulating hormone and NTS have 
appetite suppressing properties. The functional interactions between these orexigenic 
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and anorexigenic peptides, after ICV administration in rats, were described.  In 
particular, they found that administration of NTS prevents only the orexigenic effect of 
melanin-concentrating hormone, but does not prevent the appetite-stimulating effect of 
neuropeptide Y. They concluded that the interactions between these neuropeptides are 
specific, although the underlying mechanisms are yet to be explored. 
 
2.4.2 Neuroendocrine System 
 
 Involvement of NTS in neuroendocrine regulation was supported by its 
distribution, NTS-like immunoreactivity was found in the hypothalamus and anterior 
pituitary (Tyler-McMahon et al. 2000). Figure 2.4 shows that NTS has been identified to 
dose-dependently increase adrenocorticotropic hormone secretion, decrease thyroid 
stimulating hormone and lutenizing hormone (Fuxe et al. 1984) and cause an increase in 
blood glucose (Wolfe et al. 1978). 
 A study by Fuxe et al. (1984) identified that ICV injections of NTS increased 
adrenocorticotropic hormone secretion in male rats. This secretion was dose-
dependently increased, especially in the absence, but also in the presence of tyrosine 
hydroxylase (an enzyme which catalyzes the first step in the biosynthesis of 
catecholamines). Serum thyroid stimulating hormone levels were dose-dependently and 
significantly decreased in the absence and presence of tyrosine hydroxylase inhibition. 
In the case of lutenizing hormone secretion, however, NTS could only reduce serum 
lutenizing hormone levels in the presence of tyrosine hydroxylase inhibition.  
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NTS has also been shown to have a hyperglycemic effect when injected into rats. Wolfe 
et al. (1978) expanded on this finding and looked at the effect of NTS on the rate of 
glucose production and uptake. Results showed a progressive rise in plasma glucose 
concentration after IV injection of NTS, with glucose production being elevated 35-40% 
throughout the first 30 minutes after administration. Wolfe et al. (1978) therefore 
concluded that the rise in blood glucose after NTS injection was entirely due to an 
increased rate of glucose production. 
 Under all conditions reviewed by Rostene and Alexander (1997), ICV 
administration of NTS was shown to decrease plasma prolactin levels, whereas IV 
administration of NTS increased prolactin levels. This conclusion is also supported in 
the study by Fuxe et al. (1984) who identified that prolactin secretion was dose-
dependently reduced after ICV NTS administration, but only in the presence of tyrosine 
hydroxylase inhibition, which produces a hypersecretion of prolactin.  
The effect of exogenous NTS on growth hormone secretion appears to be 
dependent upon the route of administration as well as the animal model (Rostene and 
Alexander 1997).  ICV administration of NTS was identified to increase growth 
hormone levels of hypophysial portal blood (Abe et al. 1981). NTS appears to alter 
growth hormone secretion by acting at the hypothalamic level since no evidence 
indicates that NTS can act alone at the pituitary level to influence growth hormone 
secretion (Rostene and Alexander 1997). 
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2.4.3 Gastrointestinal Tract 
 
 NTS appears to cause different effects in different portions of the gastrointestinal 
tract. These effects on gastrointestinal motility clearly depend on the animal species and 
also differ according to the mode of application (Reinecke 1985). Some of the 
physiological effects of NTS on the gastrointestinal (GI) tract identified by 
Assimakopoulos et al. (2005) include: stimulation of pancreatic secretion, stimulation 
of colonic motility and inhibition of small intestine and gastric motility. 
Assimakopoulos et al. (2005) investigated the effect of IP injections of NTS, in 
partial hepatectomy rats, on intestinal barrier function in partially anesthetized rats. 
Results indicated that NTS improved intestinal barrier function and reduced 
endotoxemia, with the effect being mediated, at least in part, by the trophic, mitogenic 
and antioxidant effect on the intestinal epithelium. 
Subcutaneous injections of NTS were also shown to stimulate the growth of 
various GI tissues, including the pancreas and gastric antrum (portion of the stomach 
lined with mucosa which does not produce acid) (Feurle et al. 1987). Chronic 
subcutaneous injections of NTS increased pancreatic weight and thickness of the 
muscular and mucosal layers of the antrum without showing any effects on the stomach.  
NTS has also been shown to have a stimulatory effect on the gallbladder in some 
species (Fujimura et al. 1994). Gui et al. (2001) examined the effects of NTS on hepatic 
bile acid output and showed that intestinal NTS mRNA expression and blood levels 
were altered in rats fed chow containing bile acid and the bile acid chelator. Final 
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results indicated that enhancement of enterohepatic bile acid cycling is yet another 
mechanism by which NTS could facilitate the digestion and absorption of lipids. 
NTS has been closely associated with fat intake and utilization, with the 
ingestion of fat being the strongest stimulus for NTS release in animals and humans 
(Ferris et al. 1981). Perfusion of the small intestine with a lipid solution resulted in 
elevated NTS levels. Therefore, the intraintestinal lipid was shown to be an effective 
and specific stimulus for the release of NTS from the small intestine into the portal 
circulation. 
Piatek et al. (2005) used lipid mobilizing activity and serum lipolytic activity as 
screening parameters indicative of changes in lipid metabolism induced by NTS. The 
main effect of NTS administration observed was the inhibition of lipolytic processes in 
the adipose tissue, causing inhibition of lipid mobilizing activity and serum lipolytic 
activity.  It also appears that NTR2 receptor played a key role in changes in the lipid and 
cholesterol metabolism parameters observed. 
 
2.5 Polymorphisms 
 
Given that NTS can selectively modulate dopaminergic neurotransmission, 
Austin (2000) hypothesized that NTS dysfunction might contribute to the pathogenesis 
of neuropsychiatric disorders, particularly schizophrenia. This study identified three 
sequence variants in the human NTS gene that might alter NTS structure and function. 
Denaturing high performance liquid chromatography was used to screen 1381 bases of 
the neurotensin gene including all four exons and 283 bases of the 5’ flanking region. 
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Denaturing high performance liquid chromatography analysis revealed heteroduplexes 
in three PCR fragments. Sequencing identified three heteroduplexes as a C>G (-
166C>G), an A>G (-3A>G) and a C>A (+187C>A). Polymorphisms -166C>G and -
3A>G are located in the 5’ flanking region and 5’ UTR respectively. The third variant, 
+187C>A, results in a leucine to isoleucine change in the precursor protein at residue 
number 64 from the amino terminus. Using case-control study design and a novel 
genotyping system based upon a primer extension protocol and HPLC detection, no 
evidence supported the hypothesis that the variation in the proneurotensin gene 
contributed to susceptibility to schizophrenia.  
Restless leg syndrome has been mapped to chromosome 12 in humans, in a 
region that also contains NTS. Since, NTS is an important modulator of the 
dopaminergic transmission, it represents a strong functional and positional candidate in 
the context of restless leg syndrome (Desautels et al. 2003). Nineteen individuals were 
investigated using a combined denaturing high performance liquid chromatography and 
direct sequencing method. Analysis of the genomic sequence revealed two intronic 
polymorphisms and one variant in the 5’ UTR. The 5’ UTR variant resulted in an A to G 
transition at position –3 from the start codon. The first intronic variant resulted in an A 
to G transition while the second consisted of a T to A transition. None of the 
polymorphisms resulted in an amino acid change. None of the observed variants co-
segregated with restless leg syndrome and no disease-associated polymorphisms were 
detected in any of the analyzed individuals, indicating that it is unlikely that NTS is the 
gene responsible for restless leg syndrome. 
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 NTS receptors in the neurons of the ventral segmental area facilitate dopamine 
release, making the NTS gene an excellent candidate gene for alcohol dependence and 
for other behaviors that involve reinforcement (Vanakoski et al. 2000). Vanakoski et al. 
(2000) looked at the neurotensin 479A>G promoter variant in order to determine the 
frequency of the variant and to study the association between NTS and alcohol 
dependence in a Finnish population. They compared 229 unrelated healthy controls to 
134 unrelated alcohol-dependent subjects. In addition, 276 relatives of the alcohol-
dependent and control subjects were genotyped. The frequency of the rarer 479G allele 
was 0.07 in controls and 0.06 in alcohol-dependent subjects, and this difference was not 
statistically significant. The study therefore revealed no association between alcohol 
dependence and this marker. 
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3.0 HYPOTHESIS  
 
 Based on previous evidence that NTS has decreased food intake, body weight 
and influenced gastrointestinal function in rodent species NTS was therefore studied in 
beef cattle. NTS was chosen as a candidate gene for optimizing growth traits in beef 
cattle, for beef cattle producers seek to maximize profitability. In turn, potential NTS 
genotype associations with growth traits may prove to be an economic benefit to the 
beef cattle industry.  
Therefore, I hypothesized that potential polymorphisms within the bovine NTS 
gene may be associated with growth traits in cattle. In beef cattle particularly, I 
hypothesized that genotype variants may be associated with weaning weight and in turn 
yearling weight and hot carcass weight.  
Additional objectives included tissue expression, comparison of cattle sequence 
to various species for amino acid homology, linkage mapping, linkage disequilibrium 
and haplotype analysis of polymorphisms if more than one was discovered. 
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4.0 MATERIALS AND METHODS 
4.1 Animals 
4.1.1 Canadian Beef Reference Herd 
 
The Canadian Beef Reference Herd (CBRH) was developed by multiple 
ovulation embryo transfer in order to produce a reference herd for gene and QTL 
(quantitative trait locus) mapping (Schmutz et al. 2001a). The herd consisted of five 
purebred bulls (Angus, Hereford, Simmental, Charolais and Limousin) which were 
mated to 13 purebred heifers (Angus, Hereford, Simmental, Charolais, Limousin and 
Belgian Blue). These matings resulted in 17 full-sib families, five of which were 
purebred families and the remaining 12 were crossbred. The families ranged in size 
from two to seventeen calves per family producing a total of 136 offspring.  
These calves were born in the spring of 1997 either at the Termuende Research 
farm in Lanigan, SK or at the recipient cooperator’s farm. Calves born at the recipient 
cooperator’s farm were relocated to the Termuende Research farm within one month of 
calving. The calves were then weaned at the University of Saskatchewan feedlot where 
they were backgrounded and finished until slaughter, which occurred at 18-20 months 
of age. Growth and carcass traits were obtained for all offspring as well as the parents. 
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4.1.2 Bull Population 
  
The bull population consisted of 168 yearling bulls representing four beef breeds 
(Charolais, Angus, Hereford and Simmental). These animals were part of a previous 
study which used real-time ultrasound to predict carcass traits (Bergen et al. 1996). 
These bulls were housed at the Beef Research Unit at the University of Saskatchewan 
for a 112 day performance test in which they were fed a moderate energy ration. 
Animals were slaughtered within two weeks of the end of trial with carcass 
measurements collected on the chilled carcasses (Bergen et al. 1996).  
 
4.1.3 Steer Population 
 
This population of steers was raised in a commercial feedlot setting, but with  
additional data collected as a validation group for potential DNA tests related to traits of 
commercial significance (Quantum Genetics, Inc. unpublished data).The steer 
population consisted of 492 crossbred steers which were purchased across western 
Canada and shipped to the Lakeside Research facility in Brooks, AB for a slaughter 
trial. Steers were classified as either British or Continental type cattle based on visual 
observation and ranged in age from 12 to 16 months. These cattle were fed the same 
diet and slaughtered either at 119 or 140 days on feed (DOF). Growth characteristics 
were measured throughout the trial with carcass measurements taken post slaughter.  
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4.2 DNA and RNA Extraction 
 
DNA was extracted from all animals in the three populations outlined above,  
prior to the beginning of this research. Genomic DNA was obtained through blood 
extractions from the CBRH following the procedures of Montgomery and Sise (1990) 
while the tissue extractions were following those of Sambrook et al. (1989). Genomic 
DNA was extracted from the bull population from whole blood via a phenol/chloroform 
extraction (Fitzsimmons et al. 1998). Extracted genomic DNA from the steer population 
was supplied by an industry collaborator. RNA was also isolated using the trizol method 
(Gibco, Gaithersburg, MD), from four purebred animals (Charolais, Belgian Blue, 
Galloway and Simmental), in order to synthesize cDNA using SuperscriptTM (Gibco, 
Gaithersburg, MD). 
 
4.3 Sequencing 
 
NTS bovine genomic (GenBank NW_197475) and mRNA (GenBank M18621) 
sequences were available. These sequences were then used to design primers for the 
NTS gene. Forward (5’- CTCTGTCACATTTCCACAC -3’) and reverse (5’- GCCTGT 
TCCTGACGTTTATG -3’) primers were designed to amplify the complete NTS gene 
from cDNA in order to determine tissue expression using gel electrophoresis. This 
primer set isolated 640 bp, which contained the majority of the 5’UTR and all of the 
coding sequence. NTS amplification was attempted using cDNA from twelve different 
tissue samples (kidney, muscle, lung, liver, iris, abomasum, brain, spinal cord, small 
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intestine, rumen wall, fat tissue and skin from three random animals) in order to 
determine the location of NTS expression.  
To identify polymorphisms in mRNA, we obtained cDNA from the skin of four 
purebred beef cattle: a Charolais, Belgian Blue, Galloway and Simmental. The majority 
of the 3’untranslated region (UTR) and part of exon 4 was also isolated through the use 
of forward (5’- GAGAATAAACCCAGAAGACCC-3’) and reverse (5’- 
GATCATTCATTAAGACACGC-3’) primers. This primer set isolated a fragment 
containing 592 bp.  The same four purebred beef cattle (Charolais, Belgian Blue, 
Galloway and Simmental) were also used to isolate the 3’UTR of the NTS gene, along 
with the five sires and 13 dams of the CBRH.  
Two sets of primers were used to isolate intron 1 as a result of its large size. 
Forward (5’- CAGCTGGTGTGCATGATTC -3’) and reverse (5’- CCACCTTGAT 
GTGATCATTC -3’) primers were designed to isolate the first section of intron 1 and 
part of exon 1. This primer set isolated a fragment containing 910 bp. Forward (5’-GAA 
TGATCACATCAAGGTGG -3’) and reverse (5’-GA TGTATG CATATTGGTCAG -
3’) primers were designed for the second section of intron 1 and part of exon 2 
consisting of 952 bp from genomic DNA. The five sires of the CBRH were used to 
isolate intron 1.  
A single reaction contained 1.5 µl of 10X PCR buffer (Fermentas, Burlington, 
ON), 0.3 µl of 10mM dNTPs, 0.45 µl of 50mM MgCl2 (Fermentas, Burlington, ON), 10 
pmol of forward and reverse primers, 0.1 µl of Taq DNA polymerase (Fermentas, 
Burlington, ON) and 9.65 µl of sterile dH2O. This cocktail was added to 1 µl of DNA 
per sample to obtain a total volume of 15 µl. 
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The amplification consisted of an initial denaturation at 94° C for four minutes, 
followed by a cycle that ran 35 times: 94° C for 50s, 55s at an annealing temperature 
specific to the primer set and 72° C for 50s. A final extension of 72° C was maintained 
for four minutes. Annealing temperature for the mRNA primer set was 53° C, the 
3’UTR set was 58° C, the first section of intron 1 was 53° C and the second section was 
51° C. All reactions were performed using a Stratagene® Robocycler 40. Bromophenol 
blue marker dye (2.5 µl) (Gibco, Gaithersburg, MD) was then added to the samples 
which were then loaded onto a 2% agarose gel which ran for approximately one hour at 
80 W.   
PCR products from all three primer sets were purified using the QIAquick® Gel 
extraction kit (QIAGEN, Mississauga, ON). The purified PCR product was quantitated 
on a 2% agarose gel with a DNA MassTM ladder (Gibco, Gaithersburg, MD) and sent 
for sequencing at the Canadian National Research Council Plant Biotechnology 
Institute, Saskatoon, SK. Sequencing results were aligned and analyzed using the 
SequencherTM program (Version 4.1, Gene Codes Corporation). 
  
4.4 Genotyping 
 
PCR-RFLPs were designed for the three SNPs in the 3’UTR. SNP *287G>T 
was genotyped using new forward (5’- GTCACATAGAATGTT TGTC -3’) and reverse 
(5’- GATCATTCATTCCGCACAGA -3’) primers. The PCR product was 313 bp in 
length and was amplified as described above, with an annealing temperature of 48° C. 
The restriction enzyme Apo1 (Fermentas, Burlington, ON) cut the T allele at 58 bp in 
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order to distinguish between the two alleles of the SNP. A single digestion reaction 
consisted of 1.5 µl of tango buffer (Fermentas, Burlington, ON) and 1.0 µl of enzyme 
which was incubated for three hours at 37° C and loaded onto a 3% agarose gel. 
SNP *383T>C was genotyped using a mismatch forward primer (5’- AGAACA 
AAGTAACACC TGTC -3’) and reverse (5’- GATCATTCATTCCGCACAGA -3’) 
primer. The amplification of this 177 bp product was the same as that described above 
with the exception of the annealing temperature (57° C). The restriction enzyme BsmA1 
(Fermentas, Burlington, ON) cut the C allele at 18 bp, with the digest being the same as 
described above.  
SNP *419G>A was genotyped using the forward (5’- GCCTACCTGTCATTAA 
CCC -3’) and reverse (5’- CATTCTTTGAAGATGGTCC -3’) primers. This primer set 
amplified a 196 bp product. Once again the amplification procedure was similar with 
the annealing temperature differing (51° C). This digest was also similar to the 
previous, with the restriction enzyme (Hha1) (Fermentas) cutting the G allele at 77 bp, 
however this digest also contained 1.0 µl of BSA (bovine serum albumin) (New 
England Bio Labs, Pickering, ON). 
 
4.5  Mapping 
 
Neurotensin was linkage mapped using the CriMap program (Green et al. 1990). 
Genotypes for the sires, dams and offspring within the CBRH were obtained from the 
*419G>A SNP in order to map the gene. 
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4.6  Statistical Analysis 
 
The StatView SE+ GraphicsTM statistical program (1998 Abacus Concepts, 
Inc.) was used for preliminary analysis of the data. Simple regression was performed, 
employing the *419G>A SNP genotype as the X variable (genotype = 0, 1 or 2 guanine 
alleles) and a specific growth/carcass measurement as the Y variable. An association 
was termed significant if the P-value was < 0.05. If an association was significant, an 
unpaired t test was then used to identify if a dominant/recessive genotypic effect was 
present.  
The SAS (Statistical Analysis System) (Version 9.1.3) was also used for 
statistical analysis. The MIXED model procedure in the SAS program was used to 
analyze a factorial design in order to determine if a significant interaction, between NTS 
genotype and breed type (British or Continental), had an effect on growth/carcass 
measurements. In the steer population, NTS genotype and days on feed were also 
analyzed for an interaction effect because animals were slaughtered at two different end 
points. If an interaction effect was significant, then days on feed or British versus 
Continental type cattle were analyzed separately for genotype effect in a completely 
randomized design.
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5.0 RESULTS 
5.1 Tissue Expression 
 
 In order to determine the location of NTS tissue expression, tissue samples from 
a random crossbred steer, Holstein bull calf and a two day old crossbred calf were 
analyzed. NTS mRNA was successfully isolated from the skin, abomasum, rumen wall, 
small intestine, spinal cord and brain. Expression was not identified in the kidney, 
muscle, lung, liver, iris or fat tissue.  
 
5.2  Sequence Analysis and Polymorphisms 
 
The complete coding sequence of NTS in cattle was amplified. Figure 5.1 shows 
a comparison of our cattle NTS mRNA to previously amplified human, dog, rat and 
mouse coding sequences. When comparing the coding sequence, the dog and cattle 
sequences are closely conserved with 94% of the amino acids identical. The rat 
sequence is identified as being more divergent when compared to dog and cattle 
sequence with 75 and 77% of amino acids being identical.   
Analysis of the 5’UTR and complete coding sequence, containing both NN and 
NTS, did not reveal any SNPs in the cDNA from a Charolais, Belgian Blue, Galloway 
and Simmental or the two sequences in GenBank (NM_173945, BC102381). This does 
not preclude additional SNPs which may be present in dairy or Bos indicus breeds but is  
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Cattle:MMAGMKIQLVCMLLLAFSSWSLCSDSEEEMKALEADLLTNMHTSKISKASVPSWKMTLLNV 61 
 
Human: ------------+---------------------+-F------------H------+---- 61 
 
Dog:   ------------+-----------------------L------------S-+--------- 61 
 
Rat:    -I--++----+T--------------+++------L-----+--+--+SP---------- 60 
 
Mouse:  -R—N------LT---------------DVR-------------------P---------- 60 
 
 
Cattle:CSLVNNLNSQAEETGEFHEEELVARRKFPTALDGFSLEAMLTIYQLHKICHSRAFQHWEL 121 
 
Human: ---+-----P------V-----++---L-+----------------+------------- 121 
 
Dog:   --F------Q------F+----++---F------------------+---------+--- 121 
 
Rat:   ---+-----+---+--+++++---+----LV—D-----+--++--+---+---------+ 120 
 
Mouse: ---I—-V—-P---A-DM-DDD—-GK—-L-LV------------F—-Q---R--------I 120 
 
 
Cattle:IQEDILDTGNDKNEKEEVIKRKIPYILKRQLYENKPRRPYILKRGSYYY            170 
 
Human: -------+-----G------------------------------D----            170 
 
Dog:   ----+--+-----E------------------------------G----            170 
 
Rat:   -------H--+-TE------------------------------A----            169 
 
Mouse: -------NV----------------------------------------            169 
 
 
 
 
 
Figure 5.1: Comparison of the NTS coding region in various species. Figure adapted 
from Dong et al. (1998) and GenBank sequences (NM_173945, NM_006183, 
NM_001102381, NM_024435). Dog sequence adapted from Kislauskis et al. 1988.
 NN    NTS 
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a useful representative sample of beef breeds.  Analysis of the 3’UTR in these four 
purebred beef cattle, as well as the sires and dams of the CBRH, revealed three SNPs 
(*287G>T, *383T>C, *419G>A). 
Sequence analysis of intron 1 in the five CBRH sires revealed six intronic SNPs 
(c.73+369T>C, c.74-580C>T, c.74-495T>C, c.74-343T>C, c.74-224C>A, c.74-
214G>A). The approximate locations of the SNPs are represented in Figure 5.2. None 
of the SNPs identified changed an amino acid, since they were not located in the coding 
sequence of the gene. 
 
5.3 Linkage Mapping 
 
A PCR-RFLP was designed to detect the *419G>A SNP in the 3’UTR of exon 4 
(Figures 5.2 and 5.3). NTS was mapped to cattle chromosome 5 (Figure 5.4) by 
genotyping the parents and offspring of the CBRH for the *419G>A SNP. Genotypes 
from eight microsatellite markers were available from a previous study (Schmutz et al. 
2001b). NTS was mapped between markers BM6026 (13 cM, LOD=4.03) and RM103 (4 
cM, LOD=3.63). A QTL for carcass fat (Stone et al. 2005) was reported in this region. 
 
5.4 Linkage Disequilibrium and Haplotypes 
 
PCR-RFLPs were also designed to detect the *287G>T (Figure 5.5) and 
*383T>C SNPs (Figure 5.6) in the 3’UTR. The *287G>T and *383T>C SNPs along 
with the *419G>A SNP were genotyped for all the animals in the CBRH in order to 
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Figure 5.2: Genomic representation of the cattle neurotensin gene. Arrows indicate 
single nucleotide polymorphisms.  * indicates nucleotide number in relation to the stop 
codon. 
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Figure 5.3: PCR-RFLP agarose gel electrophoreses of the *419G>A SNP in the 3’UTR 
of the neurotensin gene.  Lane 3 = GG homozygote lane, 4 = GA heterozygote and lane 
5 = AA homozygote.
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Figure 5.4: Linkage map of cattle neurotensin on chromosome 5 relative to 
microsatellite markers. NTS mapped between BM6026 (13 cM) and RM103 (4 cM). A 
QTL for carcass fat was previously identified by Stone et al. (2005) on cattle 
chromosome 5 in close proximity to NTS.
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Figure 5.5: PCR-RFLP agarose gel electrophoreses of the *287G>T SNP in the 3’UTR 
of the neurotensin gene. Lane 1 = TT homozygote control, lane 2 = GG homozygote 
control and lane 3 = GT heterozygote control. 
TT GG GT 
313bp 
255bp 
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Figure 5.6: PCR-RFLP agarose gel electrophoreses of the *383T>C SNP in the 3’UTR 
of the neurotensin gene. Lane 1 = CT heterozygote control and lane 2 = TT homozygote 
control.
CT TT 
177bp 
159bp 
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determine if these alleles were in linkage disequilibrium (LD). Chi-square analysis was 
used to determine that there was no LD between the *287G>T and *419G>A SNPs 
(P=0.0001) nor between the *383T>C and *419G>A SNPs (P=0.0001).  In order to 
determine whether the *287G>T and *383T>C SNPs were in LD, the Fisher exact test 
was used (P=0.00033). The Fisher exact test is meant to be used if all samples have one 
or the other category, therefore, for multiple alleles you’d have to group the “not” 
together. Haplotypes were also determined for the sires and dams of the CBRH based 
on their offspring to further demonstrate independent segregation as shown in  
Figure 5.7. 
 
5.5 Allele Frequencies 
 
Allele frequencies of the A and G alleles at the *419G>A SNP were determined 
using the 145 Angus, Simmental, Charolais and Hereford bulls. Because the allele 
frequencies varied among the breeds (Table 5.1), chi-square analysis was used to 
determine if there was a significant interaction between breed type and allele frequency. 
Breed type separates breed based on their country of origin, being either of the British 
(Hereford and Angus) or Continental (Charolais and Simmental) types. Chi-square 
analysis using a continuity correction (used when at least one cell of the table has an 
expected frequency less than 5) revealed that there is not a significant (P=0.0589) 
interaction.  
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Figure 5.7: Haplotypes for the three SNPs in the 3’UTR of cattle neurotensin in one 
embryo transfer family. 
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Table 5.1: Allele frequency of SNP *419G>A in the 3’UTR of cattle neurotensin. 
Breed Type n A allele G allele 
Angus British 55 0.23 0.77 
Hereford British 20 0.00 1.00 
Simmental Continental 18 0.11 0.88 
Charolais Continental 52 0.08 0.92 
Total  145 0.13 0.87 
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The allele frequencies for the *287G>T and *383T>C SNPs were also identified in a 
random group of crossbred steers. Among the 95 steers genotyped at the *287G>T 
SNP, the T allele was shown to have a frequency of 0.02 and the G allele a frequency of 
0.98. In the 28 steers genotyped at the *383T>C SNP the C allele had a frequency of 
0.02 and the T allele of 0.98. 
 
5.6 Association Studies 
 
The *419G>A SNP was genotyped in the CBRH, the bull population and the 
steer population. In the CBRH, NTS genotype was analyzed for significant associations 
with growth and carcass traits (birth weight, carcass weight, rib eye area, grade fat, 
marbling, palatability, cutability, %lean and moisture levels). Significant associations 
between NTS genotype and rib eye area (REA), grade fat and moisture were found in 
the CBRH (Table 5.2). Rib eye area (cm2) is defined as the amount of lean muscling 
being analyzed at the longissimus muscle at the 12th rib, grade fat (mm) is the back fat 
depth over the 4th quadrant of the longissimus dorsi and moisture (mg/g) is the amount 
of water present in the lean muscle. No associations were found for birth weight or 
carcass weight in the CBRH.  
Cattle with an AA genotype had a significantly lower REA, higher grade fat and 
lower moisture level than GA or GG animals. These associations were also significant 
when using the t test. This test eliminated the AA genotypes, because of the limited  
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Table 5.2: Significant associations for SNP *419G>A in the CBRH using simple 
regression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   NTS genotype 
Trait P-value r AA GA GG 
   n=2 n=47 n=74 
Mean 
REA
1
 
(cm
2
) 
0.0021 0.272 96.50 + 0.71 103.00 + 11.40 109.80 + 13.30 
Mean 
Grade fat 
(mm) 
0.0242 0.202 12.25 + 5.30 10.30 + 3.20 8.80 + 4.30 
Mean 
Moisture 
(mg/g) 
0.0249 0.201 721.16 + 25.17 727.84 + 16.20 734.06 + 16.06 
1
REA = rib eye area 
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number of animals, and therefore only compared the GA versus GG genotypes (Table 
5.3). No significant interactions were present for NTS genotype and breed type for any 
of the traits analyzed in the CBRH. 
 In the bull population, NTS genotype was analyzed for associations with end of 
trial weight, shipping weight, carcass weight, average fat, grade fat, yield grade, rib eye 
area, marbling, cutability, %lean, %fat, start of trial fat, end of trial fat and fat deviation. 
A significant association of NTS genotype with %fat (based on the dissection of the 7th 
bone-rib into bone, muscle and fat), end-of-trial (EoT) fat (ultrasound measurement of 
fat at 112 days on feed) and fat deviation (the rate at which fat is laid down in mm over 
the trial period) was found (Table 5.4). Animals with an AA genotype were identified to 
have higher %fat and EoT fat compared to GA or GG genotypes, while animals with a 
GA genotype had a lower fat deviation compared to AA or GG animals. No significant 
interaction effects were present between NTS genotype and breed type for start of trial 
(SoT) fat (ultrasound measurement of fat), EoT fat, %fat, fat deviation, REA or grade 
fat in the bull population.  
In the steer population, carcass weight, lean meat yield, yield grade, quality grade, 
marbling, grade fat, rib eye are and hip height were analyzed for NTS genotype 
associations.  A significant interaction effect was identified between NTS genotype and 
days on feed for REA, marbling (fat deposit within a muscle based on a 1-10 scale) and 
quality grade (classified as A, AA or AAA based on age and intramuscular fat) (Table 
5.5). NTS genotype and type (British versus Continental) also showed a significant 
interaction effect for REA, grade fat, marbling and quality grade. Therefore, the steer  
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Table 5.3: Significant differences using the t test on cattle with GG versus GA 
genotypes for SNP *419G>A in the CBRH. 
Trait P-value 
REA1 0.0047 
Grade fat 0.0425 
Moisture 0.0395 
 1REA=rib eye area
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Table 5.4: Carcass and live trait associations using simple regression for cattle with 
various genotypes at the *419G>A SNP in the bull population. 
1SoT Fat = start of trial fat (ultrasound measurement) 
2EoT Fat = end of trial fat (ultrasound measurement) 
3Fat Dev. = fat deviation is the rate at which fat is put down 
4REA = rib eye area 
 
 
 
 
 
 
 
 
   NTS Genotype 
Trait P-value r AA GA GG 
   n=3 n=30 n=112 
SoT Fat1(mm) 0.1007 0.139 2.25+1.95 2.59+1.61 1.99+1.53 
EoT Fat2 (mm) 0.0362 0.178 5.17+4.65 4.93+2.63 3.89+2.38 
Fat dev.3 0.0234 0.189 1.31+4.10 0.85+4.14 3.58+5.94 
REA4 (cm2) 0.9394 0.006 95.67+18.85 96.47+12.05 96.52+13.35 
Grade fat (mm) 0.3136 0.085 5.33+2.89 4.73+2.91 4.19+2.22 
Fat (%) 0.0634 0.156 23.37+6.50 18.89+5.29 17.52+5.82 
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Table 5.5: Interaction effects between NTS genotype, days on feed and breed type on 
carcass traits in the steer population using proc MIXED model.  
Treatment REA  
P-value 
Grade Fat      
 P-value 
Marbling       
P-value 
Quality Grade 
P-value 
NTS*Type1 <.0001 0.3687 0.0012 <.0001 
NTS*DOF2 0.0178 <.0001 <.0001 <.0001 
NTS*DOF2*Type1 0.3731 0.6471 0.7223 0.7554 
1Type = Breed type (British versus Continental) 
2DOF = days on feed (119 versus 140) 
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population had to be analyzed separately for days on feed, as well as British versus 
Continental type for these traits. 
 The steer population was analyzed based on their means for REA, grade fat and 
carcass weight which were similar to those of the CBRH (Table 5.6). To determine if 
significant associations between genotype at the *419G>A SNP and marbling or quality 
grade existed in the steer population (Table 5.7), simple regression was used. Steers 
with an AA genotype had a higher quality grade followed by steers with a GA genotype 
and finally steers with a GG genotype. Steers with a GA genotype were shown to have 
lower marbling followed by steers with an AA genotype and steers with a GG genotype.  
Using a t test, cattle of GG genotypes fed to 119 days and of the Continental 
type had significantly higher marbling and a significantly lower quality grade than cattle 
with GA genotypes (Table 5.8). Cattle with AA genotypes were not included in this 
analysis because of the limited number of such animals. In general, an increase in 
marbling tends to lead to an increase in quality grade, however in this study an increase 
in marbling led to a decrease in quality grade, therefore we can conclude that these 
varying results indicate that the *419G>A SNP associations with marbling and quality 
grade do not appear to be correct.  
 To determine if a dominant/recessive genotypic effect was present, an unpaired t 
test was used comparing one homozygote and the heterozygote against the opposite 
homozygote group. Quality grade and marbling would both fit a dominant/recessive 
inheritance model (Table 5.9). No significant associations were identified for REA or 
grade fat in the steer population. 
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Table 5.6: Comparison of the means and standard deviations for carcass weight, REA 
and grade fat in the CBRH, bull population and steer population.  
Means CBRH Bull population Steer population 
REA1 (cm2) 107.04 + 14.40 102.28 + 13.90 100.76 + 10.62 
Grade fat (mm) 9.46 + 3.70 4.02 + 3.00 9.13 + 4.05 
Carcass weight (kg) 407.08 + 16.70 348.61 + 33.52 392.61 + 20.62 
1REA = rib eye area
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Table 5.7: Significant associations using simple regression between carcass traits and 
genotypes at the *419G>A SNP in the steer population. 
   NTS Genotype 
Trait P-value R AA GA GG 
   n=4 n=89 n=399 
QualityGrade 
(#A’s) 
0.0458 0.091 2.50+0.58 2.40+0.50 2.30+0.57 
Marbling (1-10)1 0.0264 0.101 7.25+0.96 7.21+1.03 7.46+0.91 
REA2 (cm2) 0.9253 0.004 92.00+6.06 101.46+10.04 100.69+10.72 
Grade fat (mm) 0.6739 0.019 12+5.57 9+3.82 9+4.09 
11=practically devoid, 10=abundant 
2REA = rib eye area 
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Table 5.8: Significant differences using the t test of cattle with GG versus GA genotypes 
for SNP *419G>A in the steer population. 
Trait 119 DOF 119 DOF 
&British 
119 DOF 
&Continental 
NTS Genotype GA GG GA GG GA GG 
n 49 188 26 94 23 94 
Mean Quality 
Grade (# A’s)  
2.35 
+0.48 
2.16 
+0.51 
2.50 
+0.51 
2.34 
+0.56 
2.18 
+0.39 
1.98 
+0.39 
P-value 0.0185 0.1924 0.0294 
Mean Marbling 
(1-10)1 
7.31 
+1.06 
7.65 
+0.91 
7.08 
+1.16 
7.36 
+1.04 
7.57 
+0.90 
7.91 
+0.65 
P-value 0.0286 0.2294 0.0348 
    11=practically devoid, 10=abundant
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Table 5.9: Significant differences using the t test of cattle with GG versus GA or AA 
genotype at SNP *419G>A in the steer population suggest marbling or quality grade 
could be inherited as dominant/recessive traits. 
 Steer population 
Trait Total 119 DOF 119 DOF 
&British 
119 DOF 
&Continental 
Quality Grade  
P-value 
0.0457 0.0084 0.1006 0.0324 
Marbling 
 P-value 
0.0221 0.0183 0.1555 0.0411 
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Comparison of the MIXED model results in the SAS program across the three 
populations are represented in Table 5.10. Grade fat remains significant in the CBRH 
using this method of analysis, while REA does not. A trend towards significance for 
marbling (P=0.0518) in the Continental type animals of the steer population was also 
present. The bull population did not show any significant associations. 
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Table 5.10: Significant association comparison between the CBRH, bull and steer 
populations using the MIXED model procedure. 
 CBRH Bull Population Steer Population 
Trait British Continental British Continental British Continental 
REA1 
(cm2) 
94.61 
+4.94 
112.02 
+12.59 
88.16 
+8.05 
105.23 
+11.64 
99.47 
+10.71 
102.18 
+10.37 
P-value 0.8195 0.0749 0.3141 0.3729 0.1861 0.8032 
Grade 
Fat (mm) 
14.29 
+3.44 
7.30 
+3.11 
6.52 
+2.75 
2.00 
+1.29 
10.62 
+4.07 
7.48 
+3.32 
P-value 0.5716 0.0243 0.4981 0.5744 0.3404 0.5778 
Marbling 
(1-10)2 
5.16 
+0.58 
4.47 
+0.75 
1.27 
+0.53 
0.50 
+0.53 
7.12 
+1.00 
7.74 
+0.73 
P-value 0.8916 0.1212 0.1525 0.1075 0.5481 0.0518 
1REA = rib eye area 
21=practically devoid, 10=abundant 
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6.0 DISCUSSION 
6.1 Expression 
 
NTS mRNA was successfully isolated from the brain and spinal cord repeating 
Carraway and Leeman (1973) who first isolated NTS from the hypothalamus of a calf. 
NTS was also found in the abomasum, rumen wall and a random stomach sample in this 
study. NTS was expressed in the fetal and early postnatal stomach of rats (Wang and 
Evers 1999). NTS was also isolated from the small intestine of a calf (Kitabgi et al. 
1976) suggesting that NTS may exist in different areas of the gastrointestinal tract. 
Kitabgi et al. (1976) isolated a tridecapeptide with the same amino acid composition as 
that of NTS from extracts of bovine intestinal tissues. This material was as potent as 
NTS in inducing hypotension in anesthetized rats and therefore indicated that the 
intestinal tridecapeptide was identical to hypothalamic NTS and it was referred to as 
intestinal NTS. Although NTS was not isolated from the abomasum or large intestine of 
Philippine water buffalo (Baltazar et al. 1998), it was isolated from the small intestine. 
NTS was also successfully isolated from the small intestine in this study. 
NTS mRNA was also found in the skin. Eedy et al. (1994) did not find NTS in 
human skin. Although NTS was not identified in liver in this study, it has been shown to 
be expressed in fetal rat liver, as well as three and seven days after birth (Wang and 
Evers 1999). Wang and Evers (1999) also showed that NTS was expressed at the earliest 
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fetal time in the small bowel. Although NTS expression was widely expressed in the 
gastrointestinal tract during fetal development in their study, expression was restricted 
to the small bowel in adults.  
 
6.2 Allele Frequencies 
 
 Allele frequencies for the *419G>A SNP were calculated for four major beef 
breeds (Table 5.1). Although the cattle populations analyzed in this study were not all of 
purebred origin, they were considered to be representative of the beef cattle industry in 
western Canada. Because the allele frequencies drastically differed across the breeds, 
chi-square analysis was used to confirm that there was no significant difference between 
the allele frequencies in British versus Continental type cattle.  
 Cattle were analyzed separately for breed type because of the growth and 
carcass differences between the two types. The study by Wheeler et al. (2005) showed 
that British animals had a higher fat thickness, smaller REA and lower retail product 
yield than Continental type animals. These animals also had lower shear force values 
with a greater percentage of carcasses graded USDA choice compared to the 
Continental type. Therefore, the Continental cattle are generally leaner and heavier 
muscled, with less marbling. The two breed types did not differ significantly in live 
weight or hot carcass weight (Wheeler et al. 2005). There were also no differences in 
the sensory panel data for tenderness or beef flavor intensity. 
The minor allele frequencies of the *287G>T and *383T>C SNPs were 0.02. 
These two SNPs were therefore not analyzed for genotype associations with production 
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traits, because if an association was found significant, the genotype frequency would be 
too low to produce an economic impact. 
 
6.3 Mapping 
 
NTS was linkage mapped to cattle chromosome 5 (Figure 5.3) using genotypes 
from eight microsatellite markers which were available from a previous study (Schmutz 
et al. 2001b). Stone et al. (2005) reported a QTL for carcass fat in cattle at the 
hematopoietic protein 1 (HEM1) and phosphodiesterase 1B (PDE1B) genes on BTA5 
(Figure 5.3). 
NTS is located on human chromosome 12 (Marondel et al. 1996) (Figure 6.1). 
The HEM1 (GenBank NM_005337) and PDE1B (GenBank NM_000924) genes were 
also shown to be located on human chromosome 12 in close proximity to the NTS gene 
(GenBank NM_006183). In dog, the NTS gene is on chromosome 15 (GenBank 
NM_006183). In mice, NTS is located on chromosome 10 (GenBank NM_024435) and 
in rats on chromosome 7.  
A comparative map of NTS, in cow, human, rat, mouse and dog, along with 
different genes located in close proximity is represented in Figure 6.1. In all five 
mammalian species, NT773 and NTS remain as a syntenic group. 
The segment containing KRTB, PDE1B, HEM1 and LALBA is inverted in 
humans compared to cattle. There also appears to be another inversion within this 
segment containing LYZ and IFNG. In the rat and mouse, the LYZ and IFNG genes are 
located on the same chromosome as the NTS gene and are in the same order as the cattle
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Figure 6.1: Comparative map of cow, human, rat, mouse and dog gene locations. 
Double slanted lines indicate chromosomal break point surrounding an inverted 
segment shown by arrows. Slanted lines indicate that the next segment is from another 
chromosome. Gene locations are adapted from: Stone et al. 2005, Solinas-Toldo et al. 
1995 and NCBI map viewer. 
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chromosome. However, in rats these genes are inverted with PDE1B, HEM1 and 
LALBA genes, while in mice the PDE1B, HEM1 and LALBA genes are all located on a 
different chromosome than NTS. This is also the same for the dog in which the HEM1, 
LALBA and IFNG genes are all located on different chromosomes compared to NTS. 
Therefore the conservation of chromosomal segments of this region of BTA5 is 
narrow. The locations of the genes distal to NTS do not appear to be conserved across 
species. Consequently, comparative gene mapping would have limited success with 
determining NTS chromosomal location across species.  
Although the three SNPs occurred within 132 bp, they were not in LD. This 
suggests that these SNPs probably arose independently over a long period of time. The 
rare allele in the *419G>A SNP occurred at a frequency of 13%, whereas the rare allele 
of the other two SNPs occurred at only 2%. This suggests that the *419G>A SNP was 
either under some selection pressure or that it occurred longer ago.   
 
6.4 Polymorphism Analysis 
 
The *419G>A SNP was located in the 3’UTR of exon 4. Although it did not 
alter an amino acid, 3’UTR SNPs have been shown to affect function in other genes. 
The review by Grzybowska et al. (2001) states that: the 3’UTR plays a role in mRNA 
stability, translation and localization. Several human diseases are caused by mutations 
in the 3’UTR sequences such as myotonic dystrophy (Aslanidis et al. 1992) and 
Alzheimer’s disease (Rajagopalan et al. 1998). Although the review by Grzybowska et 
al. (2001) identified that 3’UTR mutations have been shown to cause several human 
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diseases, these mutations differ in their function. For example, certain diseases have 
occurred as a result of altered stabilization via 3’UTR binding, translation suppression, 
antitermination mutations and inflated repeats leading to mutated transcripts lowering 
kinase synthesis (Grzybowska et al. 2001). A SNP in the 3’UTR of the CAST 
(calpastatin) gene has been shown to have a significant association with shear force in 
many beef breeds (Casas et al. 2006).  
 
6.5 Association Studies 
 
Genotype association studies revealed significant associations between the 
*419G>A SNP and REA, grade fat and moisture in the CBRH (Table 5.2). Significance 
for REA and grade fat may not have been observed in the bull population because these 
animals were fed to generate a lean breeding bull. Therefore, the diet used for the bull 
population was formulated to promote lean muscle growth (Bergen 1995)  providing the 
bulls with a lower concentrate level, whereas the CBRH was fed a ration with a high 
concentrate level in order to put down fat (Fournier 2000).  
Slaughter age also differed between the CBRH and the bull population. The 
CBRH herd was slaughtered at a fixed age, 19 months + 2 weeks, whereas the slaughter 
age of the bull population was approximately 16 months. Based on the means for 
carcass weight, we can determine that the CBRH herd was slaughtered at heavier 
weights than the bull population.  
The steer population showed means for grade fat and carcass weight that were 
similar to the CBRH rather than the bull population. The steer population also 
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represents a typical commercial feedlot group, which was the primary area of interest in 
finding an association of economic importance. A significant association between NTS 
genotype and quality grade was identified in the steer population.  A significant 
association between genotype and marbling was also identified. Quality grade was 
measured as A, AA and AAA. Marbling was measured on a 1-10 scale with 10 
representing abundant marbling. One would typically expect that higher marbling 
would result in higher quality grade. However, in the steer population, cattle of the 
various genotypes had inverse measured for quality grade and marbling score  
(Table 5.8).  
 Although cattle in all three populations had higher fat levels with the AA 
genotype (Table 5.2, 5.4, 5.7) than those with the GG genotype, no single measure of 
fat was consistently found to have significant association. Comparison of other 
significant production trait associations across the three populations could not verify a 
specific association. It was therefore concluded that the *419G>A SNP in the 3’UTR of 
the bovine NTS gene does not prove to be of economic importance to the beef cattle 
industry. 
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7.0 CONCLUSION 
 
The cattle NTS gene was successfully amplified in brain, spinal cord, small 
intestine, rumen wall, abomasum and skin of random crossbred animals. Three SNPs in 
the 3’UTR and six in intron one were identified through sequence analysis. The 
*419G>A SNP in the 3’UTR was used to map NTS to BTA 5 between markers BM6026 
(13 cM, LOD=4.03) and RM103 (4 cM, LOD=3.63) near a QTL for carcass fat (Stone 
et al. 2005). 
The three SNPs in the 3’UTR were also analyzed in order to confirm that they 
were not in linkage disequilibrium with each other. The *287G>T and *383T>C SNPs 
were not analyzed for associations with production traits as a result of their low minor 
allele frequencies. 
The *419G>A SNP was analyzed for growth and production trait associations 
across three different population of animals. No associations for growth traits were 
identified in any of the three populations used. Comparison of the significant production 
trait associations across the three populations could not verify a specific carcass trait 
association. 
 The original hypothesis stated that potential polymorphisms within the bovine 
NTS gene may be associated with growth traits in cattle, in particular with weaning 
weight and in turn yearling weight and hot carcass weight. This study was not able to 
confirm our hypothesis for the *419G>A SNP that was analyzed did not shown any 
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significant associations with growth or production traits across the three groups of 
animals studied. Therefore it was concluded that the *419G>A SNP in the 3’UTR of the 
bovine NTS gene does not prove to be of economic importance to the beef cattle 
industry.
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8.0 FUTURE RESEARCH 
 
 
In the central nervous system, NTS has been shown to produce potent 
hypothermia effects (Bissette et al. 1976), reduce locomotor activity and exhibit pain 
reducing effects (Clineschmidt et al. 1979). NTS has also been identified as a 
neuromodulator as shown by its similarity to neuroleptics (Nemeroff 1980), with 
decreased NTS signaling contributing to defects in sensorimotor gating in some animals 
with schizophrenia (Binder et al. 2001a). 
In cattle, these effects of NTS on the CNS may influence animal behaviour. 
Hypothermia effects in beef cattle may lead to either an increase or decrease in feed 
consumption depending on the degree of hypothermia. A reduction in locomotor 
activity may also influence the amount of pasture being grazed or the amount of time 
spent at a feed bunk, while pain reducing effects may be beneficial at the time of 
castration and dehorning. 
The study by Schmutz et al. (2001b) calculated the heritability of temperament 
at weaning and of habituation, across several full-sib families. From this, several QTL 
were detected for one and/or both of these traits. One of these QTL was found on 
chromosome 5, near the microsatellite RM103. This microsatellite is also located in 
close proximity to NTS.
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Therefore, based on the identification of a QTL for behavior traits located near 
the NTS gene, along with its effects on the central nervous system and role as a 
neuroleptic, future research in the relationship between the *419G>A SNP located in 
the NTS gene and behavior in beef cattle may be plausible.  
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Appendix A: Polymorphisms identified in intron 1 of the cattle neurotensin gene. 
Polymorphisms are underlined; exon sequences are in bold. 
 
 
TGTGCTCAGGTAAGCTCAGCTGCATTTCACAACTCCCTGAAATGATATCTTTTTCTGTTTTTGCAATGTG
TTGTTACTAATGCTAATGTATCTGGGGAGAAGAGTTTCTCCCTTATTCTGATTTGCTTTTTAGTGATAGA
AACTGGATATTTTCTTTCTCTGTATTTATGATTACAAGAACTGAAAATTTTCCCTTCCCTTTTTAAATTT
GCTAGGTAGTATAAGGGATTTCAATGAGACACTTCATGTTCCAGTTTGCAATGTAATCACTAGGAAAAAA
AAATGTAAAACTTAAATCAAGCTGATCTAATGAAAAGTACAGAAGTGGTGCCTGTCAAAATGCAAACTCA
TAATTCAAACTGATTGTATTTGAAATGYTTTATA......773bp......TAGYCTGTGATAAAATTGC
CAAGTACACATAATTCTAAATTGTTGCTTAATATAGAGAAACAAATCTTTCAAAGTGTGTTTTGTAAAAY
AGCATCTCAAATAAAATAAATCTCAGTGTCTTCCTTATTCCAAAATTATCAATAAGTAACTTCCTTTGGT
TTTATCTTTAAAAAATGTCTTGTACTTACCTTTTCATTATCTTGCTTTGAAAATATCAATATATATACAC
TCTATGTATATGYAGACTACTGCCAGTAAAAATTAACCAGCATATTTGATGACATCTTTGTAGTATAATC
AGGTTTTATTATCCTGAGATTCAGAGATTAAACAACTCCAGATCATCGAGAGCTCTCGGCMTAAAATCAT
RTGCCTATTTTTGTAAAAGTGCTTCTATTGTTCTATTCTGTTAGCCTAAAATAAAACTATAATTGTTTTT
TTAATATTATTATAAGGAGAATAAATACATAGCAAAGACAATAAACTTCTAAGACAAAGTTTTCTGAGAT
TAATCTTAAATATTCAAATTATAATTATATGATATGTGGTTATATAGTAAACATGTGGTTTTGATTTTAC
TCAGATC 
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Appendix B: Polymorphisms identified in the 3’UTR of the cattle neurotensin gene. 
Polymorphisms are underlined, stop codon is in bold. 
 
 
TGAGAGGATAAATATTTTATTTACATGTGATTGTGATTTCTTTTAATGAAATATCAAATTATATTTGTGT
GGAAATGTGACAGAGCACAATTATTTTGTCTCTTCTACAGTTGTGGTTTATTAGATGTGATTTTTTTCTG
CATTACTATAAATTGGACTAAATGTTTTAAAATAAATCTAGATCTTGAGCATGAAATGTTGTGTATAATT
GGAGTAGATATTAATTAAGTCACATAGAATGTTTTGTCATTTTGCAAAGCACTTAATGGGTTGTTCAAGC
AGTTAAAATKTTTGCCATTCTAAACCAAATTAAAAGAGATTAGGACAGTTTTACCGCAAAGTCTAGCCTA
CCTGTCATTAACCCAGAACAAAGTAACACCTGTTTYATTATTTGAATGTTTCATTGAACTGAAACACATG
CRCTTTTCCAAGACTTACTCATTAATCTCAGAAATGGGGAAGGCAATAGAAGTAAAATAGGACCATCTTC
AAAGAATGATTAATGAATTATTGTTAATTATGCGTGTCTTA 
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Appendix C: Chi-square analysis for linkage disequilibrium 
The five sires and 12 dams of the CBRH were genotyped for the *419G>A and 
*287G>T SNPs. 
 *287G>T  
*419G>A G/G G/T T/T Total 
A/A 0 0 0 0 
A/G 2 3 0 5 
G/G 12 0 0 12 
Total 14 3 0 17 
 
The frequency of the alleles was: 
*287G>T T = 0.09 G = 0.91 
*419G>A A = 0.15 G = 0.85 
 
The observed probability of inheriting a T at the *287G>T SNP and an A at the 
*419G>A SNP was: 
 A + T = (0.09) X (0.15) = 0.0135 
The observed probability of inheriting a G at the *287G>T SNP and an A at the 
*419G>A SNP was: 
 A + G = (0.91) X (0.15) = 0.136 
 
The expected frequency of animals with a T at the *287G>T SNP and an A at the 
*419G>A SNP was: 
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 (A + T) X n (number of animals) = 0.0135 X 17 = 0.2 
The expected frequency of animals with a G at the *287G>T SNP and an A at the 
*419G>A SNP was: 
 (A + G) X n (number of animals) = 0.136 X 17 = 2.3 
 
Alleles Observed Expected 
A + T 3 0.2 
A + G 2 2.3 
 
In the Statview program, chi-square analysis was used to identify if the observed was 
significantly different from the expected. If the outcome is significant (P<0.05) then the 
alleles are not considered to be in linkage disequilibrium.  
 
DF Chi-square Probability 
1 444.059 .0001 
 
Since the P value was equal to 0.0001, it was concluded that the A allele of the 
*419G>G SNP was not in linkage disequilibrium with the T to G allele of the *287G>T 
SNP. 
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Appendix D: Fisher exact test for linkage disequilibrium analysis 
 
NOTE: This is meant to be used if all samples have one or the other category, therefore, 
for multiple alleles you’d have to group the “not” together. 
 
This test was used to test if the T allele of the *287G>T SNP was in linkage 
disequilibrium with the alleles of the *383T>C SNP. There were a total of 18 animals 
(five sires and 13 dams of the CBRH) which were genotyped for the *287G>T and 
*383T>C SNPs. Of these animals the T allele of the *287G>T SNP and the C allele of 
the *383T>C SNP occurred in 4 animals. The T allele of the *287G>T SNP does not 
occur with the T allele of the *383T>C SNP. The G allele of the *287G>T SNP does 
not occur with the C allele of the *383T>C SNP and therefore it occurs with the T allele 
in 14 of the animals.  
 
Construct a 2 X 2 contingency table: 
 *287G>T 
*383T>C T allele Not T allele (G allele) 
C allele 4 (A) 0 (B) 
T allele 0 (C) 14 (D) 
 
Formula: 
P = (A + B)! (C + D)! (A + C)! (B + D)! P = (4)! (14)! (14)! (4)! 
         N! A! B! C! D!           18! 4! 0! 0! 14! 
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Where N = total animals (17 in this case) 
From EXCEL: 
 14  0  0  4  18 
     87178291200 1  1            24      6.40237E+15  
 
P = 0.000327 
 
The Fisher exact test indicates that the probability of this happening by chance is 
0.000327. Therefore we conclude that the *287G>T and *383T>C SNPs are not in 
linkage disequilibrium. 
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Appendix E: Cattle NTS manuscript (Animal Genetics 38, 428). 
 
No association between the neurotensin (NTS) gene and production traits in beef 
cattle 
 
K. D. Reddick and S. M. Schmutz. 
Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, 
Canada S7N 5A8. kdr730@mail.usask.ca 
 
Source/description: Neurotensin (NTS) is a 510 bp gene which encodes a 13 amino acid 
peptide which is expressed in bovine hypothalamus1 and skin (this study) (Accession 
No. DQ515198). Several studies have shown that intracerebroventricular injection of 
NTS decreased food intake in rats.2-7 The purpose of this study was to determine if 
polymorphisms discovered within the NTS gene were correlated with growth and/or 
carcass traits in beef cattle. 
 
SNP identification: The bovine NTS mRNA sequence (M18621) was used to design 
forward (5’- GAGAATAAACCCAGAAGACCC-3’) and reverse (5’- 
GATCATTCATTAAGACACGC-3’) primers. Using standard procedures, this primer 
set isolated a 592-bp fragment containing the majority of the 3’UTR and part of exon 4.  
Sequences of this amplicon were determined for four purebred beef cattle breeds 
(Charolais, Belgian Blue, Galloway and Simmental), as well as the five sires and 13 
dams of the Canadian Beef Reference Herd.8 A SNP was identified in the 3’UTR of 
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NTS (DQ515198.1:c.*419G>A, where *419 indicates 419 nucleotides 3’ of the 
translation stop codon).  
 
SNP genotyping: Primers that amplified a 196-bp fragment containing the c.*419G>A 
SNP were designed: forward (5’- GCCTACCTGTCATTAA CCC -3’) and reverse (5’- 
CATTCTTTGAAGA TGGTCC -3’). The amplicon was digested with Hhal 
(Fermentas), producing fragments of 119 bp (c.*419G allele) and 196 bp (c.*419A 
allele).  
Three groups of cattle were genotyped. The first group was the Canadian Beef 
Reference Herd, 8 which consisted of 17 full-sib families, five of which were purebred 
breeds and the remaining 12 were two-breed crosses. The second group consisted of 
168 purebred yearling bulls of the Angus, Hereford, Simmental and Charolais breeds.9 
The final group consisted of 492 crossbred steers fed at the Lakeside Research facility 
in Brooks, Alberta. All animals were analysed for associations between the NTS 
genotype and carcass traits. The Canadian Beef Reference Herd was also analysed for 
associations between the NTS SNP and growth traits. 
Allele frequencies for the c.*419G>A SNP were determined for the four 
purebred beef breeds. Frequencies of the c.*419A allele were 0.23 in Angus, 0.11 in 
Simmental, 0.08 in Charolais and 0.0 in Hereford. There was not a significant (P = 
0.0589) interaction between breed type (British vs. Continental) and allele frequency, as 
tested with a chi-squared with a continuity correction. NTS was also mapped to bovine 
chromosome 5 using genotyping data from the Canadian Beef Reference Herd,  with a 
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location 13 cM distal to BM6026 (LOD =  4.03) and 4 cM proximal to RM103 (LOD = 
3.63), close to a reported quantitative trait locus for carcass fat.10 
 
Statistical Analysis: The MIXED model procedure in SAS Version 9.1.3 was used to 
analyze a completely randomized design.  Significant values were adjusted for multiple 
comparisons. An association was considered significant if the P-value was < 0.05. All 
traits were analyzed seperately for British- and Continental- type animals. 
Tests for association of the SNP with growth traits were not significant. 
Significant trends between carcass measurements and the c.*419G>A SNP genotypes 
were present in some populations (Table 1). However, associations with carcass traits 
were not found in all three groups of cattle and therefore, were not verified.  
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Table 1: Association of the NTS c.*419G>A SNP with traits in the Canadian Beef 
Reference Herd, bull and steer populations. 
 
Canadian Beef  
Reference Herd 
Bull Population Steer Population 
Trait British Continental British Continental British Continental 
REA 
(cm2) 
94.61 
+4.94 
112.02 
+12.59 
88.16 
+8.05 
105.23 
+11.64 
99.47 
+10.71 
102.18 
+10.37 
P-value 0.8195 0.0749 0.3141 0.3729 0.1861 0.8032 
Grade Fat 
(mm) 
14.29 
+3.44 
7.30 
+3.11 
6.52 
+2.75 
2.0 
+1.29 
10.62 
+4.07 
7.48 
+3.32 
P-value 0.5716 0.0243 0.4981 0.5744 0.3404 0.5778 
Marbling 
(1-10)1 
5.16 
+0.58 
4.47 
+0.75 
1.27 
+0.53 
0.50 
+0.53 
7.12 
+1.00 
7.74 
+0.73 
P-value 0.8916 0.1212 0.1525 0.1075 0.5481 0.0518 
Carcass 
weight 
(kg) 
429.89 
+22.75 
436.47 
+38.47 
337.84 
+34.25 
336.50 
+34.26 
390.77 
+20.55 
394.59 
+20.54 
P-value 0.2759 0.9306 0.5369 0.2186 0.9235 0.5958 
11=practically devoid, 10=abundant 
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Appendix F: Phenol/Chloroform Extraction of DNA from blood (adapted from 
Fitzsimmons et al. 1998) 
 
1. Mix 500 µl of blood with 500 µl of lysis buffer, vortex. 
2. Spin at 10000rpm for 5 min. 
3. Remove supernatant, leaving pellet. 
4. Add another 500µls of lysis buffer, vortex until pellet is resuspended. 
5. Spin 10000rpm for 5 min. 
6. Remove supernatant, leave pellet. 
7. Repeat steps 5 and 6, until supernatant is clear or not red anymore. 
8. Remove supernatant. 
9. Resuspend pellet in 500µl of PCR extraction buffer. 
10. Add 10 µl of 20 ngs/ml Proteinase K and incubate O/N at 65° C. If sample is really 
yellow, brown or red after incubation it should be phenol/chloroform extracted. 
 
Phenol/chloroform Extraction 
Mix sample with an equal volume of phenol/CHCL3. Mix my inverting the tube for 
several minutes. Spin at 10000rpm for 5 min. Transfer top layer to a new eppendorf. 
Add an equal volume of CHCL3 invert tube for several min. Spin at 10000rpm for 5 
min. Transfer top layer to new eppendorf and carry on. 
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11. Precipitate – Add 1/10 the volume of 3M NaAcetate pH 5.5 ~ 50µl, mix by 
inversion, add 2X the volume of 95% ETOH~ 1000 µl, mix and store for several 
hours or O/N at -20° C. 
12. Spin 13000rpm for 15 min. Remove supernatant. Wash 1X with 500µl of 70% 
ETOH (add ETOH then vortex). Spin at 13000rpm for 10 min. Remove 
supernatant. 
13. Resuspend in 400 µl of 1XTE. Can be incubated for several hours or O/N at 55° C. 
14. Store sample at 4° C until use. Use 1µl of this for your PCR template. For long 
term storage store at -80° C. 
 
Lysis Buffer   250mls  500mls 
Sucrose 0.32M  27.38gms  54.76gms 
MgCl2 5mM   0.25gms  0.50gms 
1% Triton X   2.5mls   5.0mls 
Tris 10mM pH 7.5  1.25mls  2,5mls of 2M Tris 
 
PCR Extraction Buffer 250mls  500mls 
KCl 50mM   0.93gm or 12.5mls 1.86gms or 25mls of 1M KCl 
Tris-HCl 10mM pH 8.3 1.25mls  2.5mls of 2M Tris 
MgCl2 2.5mM   0.12gms  0.25gms 
Gelatin 0.1mg/ml  0.25gms  0.50gms 
Tween 20 0.45%  1.125mls  2.25mls 
Nonident P40 0.45%  1.125mls  2.25mls 
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Appendix G: DNA extraction from fresh tissue (adapted from Sambrook et al. 1989) 
 
1. Drop freshly excised tissue into liquid nitrogen in a stainless steel blender. 
2. Blend until tissue is ground to a powder 
3. Allow liquid nitrogen to evaporate, add powdered tissue  to 10 volumes of 
extraction buffer in a beaker 
4. Shake the beaker to submerge the powder 
5. Transfer solution to a 50 ml centrifuge tube, incubate for 1 hour at 37° C 
6. Add proteinase K to a final concentration of 100 ng/ml. Gently mix in  the enzyme 
7. Place in a water bath for 3 hours at 50° C. Mix periodically. 
8. Cool solution to room temperature. Ass equal volume of phenol equilibrated with 
0.5M Tris Cl, pH 8.0. Mix the two phases by inverting for 10 min. 
9. Transfer aqueous phase to a clean centrifuge tube and repeat the extraction with 
phenol twice. 
10. Dialyze the aqueous phases at 4° C four times against 4 liters of a solution of 
50mM Tris Cl and 10mM EDTA. Allow room for the volume of the sample to 
increase 1.5 to 2.0 fold. 
11. Measure the absorbance of the DNA at 260nm and 280nm. 
12. Calculate concentration of DNA 
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Appendix H: High Salt DNA extraction from white blood cells (adapted from 
Montgomery and Sise 1990) 
 
1. While blood cells collected following the lysis of red blood cells in 2.5 volumes of 
cold sterile lysing solution. 
2. Hold on ice for approximately 2-10 min until red blood lysis is observed (change in 
color). 
3. Spin at a relative centrifugal force (RCF) of 2000 for 10 min at 4° C. 
4. Resuspend pelleted white blood cells with a Pasteur pipette and wash twice in 10ml 
of Tris buffered saline. 
5. Pellet cells between washes at an approximate RCF of 1000 for 3 min. 
6. Resuspend cells by vigorous vortexing in 9ml of TE. 
7. Add 50 µl of Proteinase K and 0.5ml 0.5M EDTA, pH 8.0, and mix. 
8. Add sodium dodecylsulphate while gently swirling tubes. 
9. Incubate at 50° C in a water bath, mixing occasionally, for 3 hours. 
10. Add 4.3ml of a saturated NaCl solution and shake vigorously for 30 sec. 
11. Spin at RCF 2000 for 10 min. 
12. Transfer supernatant DNA to a clean glass tube and add two volumes of 95% 
ethanol. 
13. Spool out DNA and resuspend in TE and measure the concentration of the DNA in 
a scanning spectrometer. 
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Appendix I: RNA extraction method (TriZol Method, Gibco, Gaithersburg, MD) 
1. Grind tissue sample in 1ml of reagent per 50-100mg of tissues. The sample should 
not exceed 10% of the volume of TRIzol reagent used for grinding. 
2. Incubate samples for 5 min to permit the complete dissociation of nucleoprotein 
complexes.  
3. Add 0.2 ml of chloroform per 1 ml of TRIzol reagent. Shake tubes by hand for 15 
sec and incubate for 2 or 3 min. 
4. Centrifuge the samples at no more than 12,000 x g for 15 min at 4° C.  
5. Transfer the aqueous phase (top layer containing the RNA) to a fresh tube. Add 0.5 
ml of isopropanol per 1 ml of TRIzol reagent. 
6. Incubate samples for 10 min at -20° C and centrifuge at no more than 12,000 x g 
for 10 min. 
7. Remove the supernatant. Wash pelleted RNA once with 75% ethanol per 1 ml of 
TRIzol reagent. 
8. Mix sample and centrifuge at no more than 7,500 x g for 5 min at 4° C.  
9. Briefly dry the RNA pellet (do not dry completely as this will decrease its 
solubility).  
10. Dissolve RNA in DEPC-treated water and incubate for 10 min at 55° C to 60° C. 
Store RNA as 8 µl aliquot, at -80° C. 
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Appendix J: cDNA synthesis (SuperscriptTM Gibco, Gaithersburg, MD) 
DNase I Digestion of RNA Preparation 
1. Add the following to a 0.5 ml tube on ice: 
Total RNA   1-2 µg 
10X reaction buffer  1 µl 
Amplification grade DNase I 1 µl 
DEPC-treated water  to 10 µl 
2. Incubate at room temperature for 15 min.  
3. Add 1 µl of 25 mM EDTA. 
4. Incubate for 15 min at 65° C to heat inactivate DNase I, and then place on ice for 
1 min. 
5. Collect the reaction by brief centrifuge. 
First strand cDNA synthesis using Oligo (dT) 
1. Mix and briefly centrifuge each sample before use. 
2. Prepare RNA/primer mixtures in sterile 0.5 ml tubes as follows: 
1 to 5 µg total RNA  n µl 
Oligo (dT) 12-18(0.5 µg/µl) 1 µl 
3. Incubate each sample at 70° C for 10 min and incubate on ice for at least 1 min. 
4. Prepare the following reaction mixture: 
10X PCR buffer  2 µl 
25 mM MgCl2   2 µl 
10 mM dNTP mix 1 µl 
0.1 M DTT  2 µl 
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5. Add 7 µl of reaction mixture to each RNA/primer mixture, mix gently and collect 
by brief centrifugation. 
6. Incubate at 42° C for 5 min. 
7. Add 1 µl of SUPERSCRIPT II RT to each tube, mix, and incubate for 42° C for 
50 min. 
8. Terminate the reactions at 70° C for 15 min. Chill on ice. 
9. Collect the reactions by brief centrifugation and add 1 µl of RNase H to each tube 
and incubate for 20 min at 37° C. 
10. Store cDNA as 5 µl aliquots at -70° C. 
 
 
 
 
 
 
 
